Qiu-Tang Zeng
Overview
Explore the profile of Qiu-Tang Zeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang F, Xu C, He Q, Cai J, Li X, Wang D, et al.
Nat Genet
. 2011 Mar;
43(4):345-9.
PMID: 21378986
Coronary artery disease (CAD) causes more than 700,000 deaths each year in China. Previous genome-wide association studies (GWAS) in populations of European ancestry identified several genetic loci for CAD, but...
12.
Liu X, Ji Q, Huang Y, Zeng Q
Med Hypotheses
. 2011 Feb;
76(4):593-5.
PMID: 21292406
Vascular wall chronic inflammation plays a critical role in the development and progression of cardiovascular diseases such as atherosclerosis and hypertension. Circulating and tissue angiotensin II can induce potent inflammatory...
13.
Yi G, Zeng Q, Mao X, Cheng M, Yang X, Liu H, et al.
Cytokine
. 2010 Dec;
53(3):320-6.
PMID: 21177121
Background: CXCL16 has been shown to be involved in atherosclerotic lesion development, but its role in preexisting lesions is still unclear. This study aims to assess the effect of CXCL16...
14.
Mao X, Zeng Q, Wang X, Cao L
Zhongguo Ying Yong Sheng Li Xue Za Zhi
. 2010 Dec;
21(3):311-4.
PMID: 21162206
Aim: To study the mechanism of the therapeutic angiogenesis effect of bone marrow stromal cells (BMSCs) implantation on rat acute myocardial infarction models. Methods: The rat acute myocardial infarction models...
15.
Nie S, Wang X, Qiao S, Zeng Q, Jiang J, Liu X, et al.
J Zhejiang Univ Sci B
. 2010 Dec;
11(12):895-904.
PMID: 21121066
Objective: Angiogenic therapy is emerging as a potential strategy for the treatment of ischemic heart disease but is limited by a relatively short half-life of growth factors. Fibrin glue (FG)...
16.
Mao Y, Wang S, Mao X, Zeng Q, Li Y
Int J Cardiol
. 2010 Nov;
146(3):432-3.
PMID: 21094546
No abstract available.
17.
Peng Y, Cheng L, Zeng Q, Shi Y, Bao X, Mao X, et al.
Cell Biol Int
. 2010 Feb;
34(5):447-53.
PMID: 20132097
Many studies have suggested that VSMC (vascular smooth muscle cell) apoptosis plays a key role in destabilization and rupture of atherosclerotic plaques. Therefore protection for VSMCs from apoptosis is a...
18.
Sheng F, Xu R, Cheng L, Zeng Q, Gao W, Wang W, et al.
Acta Cardiol
. 2010 Feb;
64(6):779-85.
PMID: 20128155
Objective: The objective of this study was to investigate the effect of simvastatin on TLR4,TNF-alpha and IL-6 expression in the myocardium and its relation to left ventricular (LV) remodelling in...
19.
Li S, Wang X, Zeng Q, Feng Y, Cheng X, Mao X, et al.
Heart Vessels
. 2010 Jan;
24(6):446-53.
PMID: 20108078
Previous studies demonstrated that metformin has obvious antiatherogenic properties, but the exact mechanism remains unclear. Therefore, we established an atherosclerotic rabbit model in order to investigate the potential effects of...
20.
Wang Y, Yang X, Cheng B, Mei C, Li Q, Xiao H, et al.
Phytother Res
. 2009 Aug;
24(3):393-8.
PMID: 19653192
Astragalus polysaccharide (APS), the main extract from the traditional Chinese medicinal herb Astragalus membranaceus, has been reported to benefit the treatment of immune-inflammatory diseases and metabolic disorders. In atherosclerotic plaques,...